Thorne Brain Factors, 30 Capsules
UPC: 693749013433
Thorne's Brain Factors is a dietary supplement formulated to support cognitive health, with a focus on promoting BDNF and NAD+ levels in the body. It combines Nicotinamide Riboside at 415 mg per capsule, a form of vitamin B3 that serves as a precursor to NAD+, alongside 100 mg of CognatiQ™ Coffee Fruit extract, which is derived from whole coffee fruit and linked to BDNF support in research. The formula includes 85 mg of Betaine Anhydrous, intended to aid methylation processes that may optimize the effects of Nicotinamide Riboside.
This product uses Thorne's exclusive Nicotinamide Riboside and a patented coffee fruit extract, CognatiQ™, which is noted for its whole-fruit sourcing. The manufacturer states it is designed to help with focus, memory, and reducing brain fog, particularly in aging or stressed individuals, by supporting cellular energy and brain cell growth. It comes in a 30-capsule bottle with vegetarian capsules and is manufactured in the USA, with third-party testing for label accuracy and contaminants.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Nicotinamide Riboside Hydrogen Malate | 415 mg | * |
| CognatiQ™ Coffee Fruit extract (whole fruit) (Coffea arabica) | 100 mg | * |
| Betaine Anhydrous (Trimethylglycine) | 85 mg | * |
| † Daily Value not established | ||
Other Ingredients
Hypromellose (derived from cellulose) capsule, calcium laurate.
Manufactured in the USA using U.S. & imported ingredients.
Certifications & Claims
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
Take 1 capsule daily or as recommended by your health-care practitioner.
Warning
Use only if bottle is sealed. Store tightly sealed in a cool, dry place. If pregnant, consult your health-care practitioner before using this product.
Product Info
- Brand
- Thorne
- UPC
- 693749013433
- Package Qty
- 30 count
- Dimensions
- 3.25 x 1.8 x 1.8 in
- Shipping Weight
- 0.1 lb
- First Available
- 06/2022
